세포치료용 인체 원료 시장 규모는 향후 몇 년 동안 2029년까지 연평균 20.1%의 성장률로 70억 5,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 치료 용도 확대, 환자 인식 증가, 유리한 규제 프레임워크, 바이오 의약품 부문의 성장, 제조 공정 개선 등에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 동종 요법의 채택, 인공지능의 통합, 기성품 세포치료제 증가, 3D 바이오프린팅 기술의 사용, 하이브리드 세포치료제의 개발 등이 있습니다.
재생의료의 채택 확대가 향후 몇 년간 세포치료용 인체 원료 시장의 원동력이 될 것으로 예측됩니다. 재생의료는 정상적인 기능 회복을 목표로 신체가 본래 가지고 있는 재생 능력이나 줄기세포, 조직공학, 유전자 치료 등의 외부적인 방법을 이용하여 손상된 조직이나 장기를 복구, 대체, 재생하는 것을 목적으로 합니다. 재생의료가 주목받게 된 배경에는 생명공학의 발전, 세포 메커니즘에 대한 더 깊은 이해, 개인 맞춤형 의료에 대한 수요 증가, 그리고 지금까지 충족되지 않았던 의료 수요를 충족시킬 수 있는 가능성 등이 있습니다. 세포치료와 인체 원료는 다양한 건강 상태에 대한 표준화된 신뢰할 수 있는 치료법을 만드는 데 필수적인 세포 기반 치료에 필요한 생물학적 성분을 공급함으로써 이러한 발전에 중요한 역할을 하고 있습니다. 예를 들어, 미국 비영리단체 Alliance for Regenerative Medicine의 보고서에 따르면, 2023년 1분기 전 세계 세포, 유전자, 조직공학 치료제 개발업체는 2,760개사로 2022년 1분기 1,369개사 대비 101% 증가하였습니다. 그 결과, 재생의료의 보급이 세포치료용 인체 원료 시장의 성장을 견인하고 있습니다.
세포치료용 인체 원료 시장의 주요 기업들은 세포치료제 개발을 촉진하기 위해 화학적으로 정의된 세포배양 배지 개발에 점점 더 집중하고 있습니다. 세포 배양 배지는 자연 환경 밖에서 세포가 시험관 내에서 증식 및 증식하는 데 필요한 필수 영양소, 성장 인자, 환경 조건을 공급하도록 설계된 영양이 풍부한 용액입니다. 예를 들어, 2023년 5월 스위스에 본사를 둔 헬스케어 제조 조직인 Lonza Group AG는 화학적으로 정의된 제형, 무혈청 및 동물성 성분이 없는 구성, 재조합 단백질, 강화된 배양 및 배치 지원, 용도 지원 등을 특징으로 하는 TheraPEAK T-IVO 세포배양 배지를 발표했습니다. VIVO 세포배양 배지를 출시하여 세포치료제 제조의 일관성, 안전성, 규제 준수성을 확보하였습니다. 이 배지는 동물성 성분을 배제하고, 화학적으로 정의된 제제를 채택하고, 규제 당국을 고려한 특성을 도입하여 안전성, 품질, 규제 준수 향상에 기여하는 등 기술적으로 큰 진전을 이루었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 세포치료용 인체 원료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 세포치료용 인체 원료 시장 : 성장률 분석
- 세계의 세포치료용 인체 원료 시장 실적 : 규모와 성장, 2019-2024
- 세계의 세포치료용 인체 원료 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 세포치료용 인체 원료 전체 시장(TAM)
제6장 시장 세분화
- 세계의 세포치료용 인체 원료 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세포배양 배지
- 세포배양 혈청
- 세포배양 보충제
- 시약 및 완충액
- 기타 원재료
- 세계의 세포치료용 인체 원료 시장 : 세포치료 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 수상세포 요법
- NK세포 치료
- 줄기세포 요법
- T 세포치료
- 세계의 세포치료용 인체 원료 시장 : 최종 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 바이오의약품 및 제약회사
- 계약연구기관(CRO) 및 계약 제조 기관(CMO)
- 학술연구기관
- 세계의 세포치료용 인체 원료 시장 세포배양 배지 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 무혈청 배지
- 혈청 기반 배지
- 정의된 미디어
- 전문 미디어
- 세계의 세포치료용 인체 원료 시장 : 세포배양 혈청 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 소 태아 혈청
- 인간 혈청
- 어미소 혈청
- 세계의 세포치료용 인체 원료 시장 : 세포배양 보충제 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 성장인자
- 사이토카인
- 펩티드
- 세계의 세포치료용 인체 원료 시장 : 시약 및 완충액 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 효소(트립신)
- pH 완충액
- 동결 보호제
- 세계의 세포치료용 인체 원료 시장 : 기타 원재료 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 유리 DNA
- 혈장 및 혈소판풍부혈장(PRP)
- 바이알 및 보존 용기
제7장 지역별/국가별 분석
- 세계의 세포치료용 인체 원료 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 세포치료용 인체 원료 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 세포치료용 인체 원료 시장 : 경쟁 구도
- 세포치료용 인체 원료 시장 : 기업 개요
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
- Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Lonza Group Ltd.
- Grifols S.A.
- WuXi AppTec
- Catalent Inc.
- Sartorius AG
- Charles River Laboratories
- Bio-Rad Laboratories Inc.
- Pall Corporation
- Bio-Techne Corporation
- Miltenyi Biotec
- Actylis
- STEMCELL Technologies
- Takara Bio Inc.
- Vericel Corporation
- ACROBiosystems
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 세포치료용 인체 원료 시장(2029년) : 새로운 기회를 제공하는 국가
- 세포치료용 인체 원료 시장(2029년) : 새로운 기회를 제공하는 부문
- 세포치료용 인체 원료 시장(2029년) : 성장 전략
제36장 부록
LSH
Cell therapy human raw materials encompass biological substances derived from human sources, including cells, tissues, and blood components, utilized as foundational elements in the development and manufacturing of cell-based therapeutic products. These raw materials play crucial roles in various stages of cell therapy production aimed at creating treatments for diseases such as cancer, genetic disorders, and degenerative conditions.
The primary product types of cell therapy human raw materials include cell culture media, cell culture serum, cell culture supplements, reagents and buffers, and others. Cell culture media are solutions designed to provide nutrients and an optimal environment for cell growth outside their natural setting, which is essential for laboratory-based cell studies. These products find application in various types of cell therapies, including dendritic cell therapy, natural killer (NK) cell therapy, stem cell therapy, and T-cell therapy. End users encompass biopharmaceutical and pharmaceutical companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), as well as academic and research institutions.
The cell therapy human raw materials market research report is one of a series of new reports from The Business Research Company that provides cell therapy human raw materials market statistics, including cell therapy human raw materials industry global market size, regional shares, competitors with an cell therapy human raw materials market share, detailed cell therapy human raw materials market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy human raw materials industry. This cell therapy human raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell therapy human raw materials market size has grown exponentially in recent years. It will grow from $2.82 billion in 2024 to $3.39 billion in 2025 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, high demand for regenerative medicines, governmental funding and support, and growing healthcare expenditure.
The cell therapy human raw materials market size is expected to see exponential growth in the next few years. It will grow to $7.05 billion in 2029 at a compound annual growth rate (CAGR) of 20.1%. The growth in the forecast period can be attributed to expanding therapeutic applications, rising patient awareness, favorable regulatory frameworks, a growing biopharmaceutical sector, and improved manufacturing processes. Major trends in the forecast period include the adoption of allogeneic therapies, the integration of artificial intelligence, an increase in off-the-shelf cell therapies, the use of 3D bioprinting technology, and the and the development of hybrid cell therapies.
The growing adoption of regenerative medicine is expected to propel the cell therapy human raw materials market in the coming years. Regenerative medicine aims to repair, replace, or regenerate damaged tissues and organs by utilizing the body's inherent regenerative abilities or external methods such as stem cells, tissue engineering, or gene therapy, all with the goal of restoring normal function. The increased prominence of regenerative medicine is driven by advancements in biotechnology, a better understanding of cellular mechanisms, the rising demand for personalized medicine, and its potential to address previously unmet medical needs. Cell therapy and human raw materials play a crucial role in this progress by supplying the necessary biological components for cell-based therapies, which are essential for creating standardized and reliable treatments for various health conditions. For example, a report from the Alliance for Regenerative Medicine, a US-based non-profit, revealed that in Q1 2023, there were 2,760 cell, gene, and tissue-engineering therapeutic developers globally, marking a 101% increase from 1,369 in Q1 2022. As a result, the increasing adoption of regenerative medicine is fueling the growth of the cell therapy human raw materials market.
Leading companies in the cell therapy human raw materials market are increasingly focusing on the development of chemically defined cell culture media to expedite cell therapy development. A cell culture medium is a nutrient-rich solution designed to furnish essential nutrients, growth factors, and environmental conditions necessary for the in vitro growth and propagation of cells outside their natural environment. For example, in May 2023, Lonza Group AG, a Switzerland-based healthcare manufacturing organization, introduced the TheraPEAK T-VIVO Cell Culture Medium, featuring a chemically defined formulation, serum-free and animal component-free composition, recombinant proteins, enhanced culture and expansion support, and application assistance, ensuring consistency, safety, and regulatory compliance in cell therapy manufacturing. This medium represents significant technological advancements by eliminating animal components, adopting a chemically defined formulation, and incorporating regulatory-friendly characteristics, thereby contributing to improved safety, quality, and regulatory compliance.
In January 2022, Thermo Fisher Scientific Inc., a US-based scientific research and laboratory services company, completed the acquisition of PeproTech Inc. for $1.85 billion. This strategic acquisition expands Thermo Fisher's recombinant protein portfolio, aligns with its biosciences business, and strengthens its market position, impacting the cell therapy human raw materials market by enhancing product offerings and market capabilities. PeproTech Inc. is a US-based biotechnology company specializing in manufacturing products for life science research, including cytokines, antibodies, and cell culture media.
Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Lonza Group Ltd., Grifols S.A., WuXi AppTec, Catalent Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Pall Corporation, Bio-Techne Corporation, Miltenyi Biotec, Actylis, STEMCELL Technologies, Takara Bio Inc., Vericel Corporation, ACROBiosystems, BioIVT LLC, Orgenesis Inc., PromoCell GMBH, ViaCyte Inc., AllCells LLC, Sartorius CellGenix GmbH, Fujifilm Cellular Dynamics Inc., Mesoblast Limited, RoosterBio Inc., Thermogenesis Holdings Inc.
North America was the largest region in the cell therapy human raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cell therapy human raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cell therapy human raw materials market consists of sales of primary cells, stem cell banks, tissue scaffolds, cryopreservation media, cell separation products, and extracellular matrices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Therapy Human Raw Materials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cell therapy human raw materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cell therapy human raw materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell therapy human raw materials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Cell Culture Media; Cell Culture Sera; Cell Culture Supplements; Reagents And Buffers; Other Raw Materials
- 2) By Type Of Cell Therapy: Dendritic Cell Therapy; Natural Killer (NK) Cell Therapy; Stem Cell Therapy; T-Cell Therapy
- 3) By End-Use: Biopharmaceutical And Pharmaceutical Companies; Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs); Academic And Research Institutions
- Subsegments:
- 1) By Cell Culture Media: Serum-Free Media; Serum-Based Media; Defined Media; Specialized Media (E.G., For Stem Cells)
- 2) By Cell Culture Sera: Fetal Bovine Serum (FBS); Human Serum; Adult Bovine Serum
- 3) By Cell Culture Supplements: Growth Factors; Cytokines; Peptides
- 4) By Reagents And Buffers: Enzymes (E.G., Trypsin); Ph Buffers; Cryoprotectants
- 5) By Other Raw Materials: Cell-Free DNA; Plasma And Platelet-Rich Plasma (PRP); Vials And Storage Containers
- Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; GE Healthcare; Corning Incorporated
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cell Therapy Human Raw Materials Market Characteristics
3. Cell Therapy Human Raw Materials Market Trends And Strategies
4. Cell Therapy Human Raw Materials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Cell Therapy Human Raw Materials Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cell Therapy Human Raw Materials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cell Therapy Human Raw Materials Market Growth Rate Analysis
- 5.4. Global Cell Therapy Human Raw Materials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cell Therapy Human Raw Materials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cell Therapy Human Raw Materials Total Addressable Market (TAM)
6. Cell Therapy Human Raw Materials Market Segmentation
- 6.1. Global Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell Culture Media
- Cell Culture Sera
- Cell Culture Supplements
- Reagents And Buffers
- Other Raw Materials
- 6.2. Global Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dendritic Cell Therapy
- Natural Killer (NK) Cell Therapy
- Stem Cell Therapy
- T-Cell Therapy
- 6.3. Global Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biopharmaceutical And Pharmaceutical Companies
- Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs)
- Academic And Research Institutions
- 6.4. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Cell Culture Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Serum-Free Media
- Serum-Based Media
- Defined Media
- Specialized Media
- 6.5. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Cell Culture Sera, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Fetal Bovine Serum
- Human Serum
- Adult Bovine Serum
- 6.6. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Cell Culture Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Growth Factors
- Cytokines
- Peptides
- 6.7. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Reagents And Buffers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Enzymes (Trypsin)
- pH Buffers
- Cryoprotectants
- 6.8. Global Cell Therapy Human Raw Materials Market, Sub-Segmentation Of Other Raw Materials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell-Free DNA
- Plasma And Platelet-Rich Plasma (PRP)
- Vials And Storage Containers
7. Cell Therapy Human Raw Materials Market Regional And Country Analysis
- 7.1. Global Cell Therapy Human Raw Materials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cell Therapy Human Raw Materials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cell Therapy Human Raw Materials Market
- 8.1. Asia-Pacific Cell Therapy Human Raw Materials Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cell Therapy Human Raw Materials Market
- 9.1. China Cell Therapy Human Raw Materials Market Overview
- 9.2. China Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cell Therapy Human Raw Materials Market
- 10.1. India Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cell Therapy Human Raw Materials Market
- 11.1. Japan Cell Therapy Human Raw Materials Market Overview
- 11.2. Japan Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cell Therapy Human Raw Materials Market
- 12.1. Australia Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cell Therapy Human Raw Materials Market
- 13.1. Indonesia Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cell Therapy Human Raw Materials Market
- 14.1. South Korea Cell Therapy Human Raw Materials Market Overview
- 14.2. South Korea Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cell Therapy Human Raw Materials Market
- 15.1. Western Europe Cell Therapy Human Raw Materials Market Overview
- 15.2. Western Europe Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cell Therapy Human Raw Materials Market
- 16.1. UK Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cell Therapy Human Raw Materials Market
- 17.1. Germany Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cell Therapy Human Raw Materials Market
- 18.1. France Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cell Therapy Human Raw Materials Market
- 19.1. Italy Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cell Therapy Human Raw Materials Market
- 20.1. Spain Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cell Therapy Human Raw Materials Market
- 21.1. Eastern Europe Cell Therapy Human Raw Materials Market Overview
- 21.2. Eastern Europe Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cell Therapy Human Raw Materials Market
- 22.1. Russia Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cell Therapy Human Raw Materials Market
- 23.1. North America Cell Therapy Human Raw Materials Market Overview
- 23.2. North America Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cell Therapy Human Raw Materials Market
- 24.1. USA Cell Therapy Human Raw Materials Market Overview
- 24.2. USA Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cell Therapy Human Raw Materials Market
- 25.1. Canada Cell Therapy Human Raw Materials Market Overview
- 25.2. Canada Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cell Therapy Human Raw Materials Market
- 26.1. South America Cell Therapy Human Raw Materials Market Overview
- 26.2. South America Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cell Therapy Human Raw Materials Market
- 27.1. Brazil Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cell Therapy Human Raw Materials Market
- 28.1. Middle East Cell Therapy Human Raw Materials Market Overview
- 28.2. Middle East Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cell Therapy Human Raw Materials Market
- 29.1. Africa Cell Therapy Human Raw Materials Market Overview
- 29.2. Africa Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cell Therapy Human Raw Materials Market Competitive Landscape And Company Profiles
- 30.1. Cell Therapy Human Raw Materials Market Competitive Landscape
- 30.2. Cell Therapy Human Raw Materials Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
31. Cell Therapy Human Raw Materials Market Other Major And Innovative Companies
- 31.1. Lonza Group Ltd.
- 31.2. Grifols S.A.
- 31.3. WuXi AppTec
- 31.4. Catalent Inc.
- 31.5. Sartorius AG
- 31.6. Charles River Laboratories
- 31.7. Bio-Rad Laboratories Inc.
- 31.8. Pall Corporation
- 31.9. Bio-Techne Corporation
- 31.10. Miltenyi Biotec
- 31.11. Actylis
- 31.12. STEMCELL Technologies
- 31.13. Takara Bio Inc.
- 31.14. Vericel Corporation
- 31.15. ACROBiosystems
32. Global Cell Therapy Human Raw Materials Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cell Therapy Human Raw Materials Market
34. Recent Developments In The Cell Therapy Human Raw Materials Market
35. Cell Therapy Human Raw Materials Market High Potential Countries, Segments and Strategies
- 35.1 Cell Therapy Human Raw Materials Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cell Therapy Human Raw Materials Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cell Therapy Human Raw Materials Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
